These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 989788)

  • 1. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
    Abildgaard CF; Britton M; Harrison J
    J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM; Penner JA
    N Engl J Med; 1974 Jul; 291(4):164-7. PubMed ID: 4834485
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
    Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
    N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of the effectiveness of prothrombin complex concentrates in controlling hemorrhage in patients with hemophilia and anti-Factor VIII antibodies.
    Blatt PM; Ménaché D; Roberts HR
    Thromb Haemost; 1980 Aug; 44(1):39-42. PubMed ID: 6775386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic use of fraction P.P.S.B.
    Soulier JP; Josso F; Steinbuch M; Cosson A
    Bibl Haematol; 1968; 29():1127-33. PubMed ID: 5700308
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor.
    Lowe GD; Harvie A; Forbes CD; Prentice CR
    Br Med J; 1976 Nov; 2(6044):1110-1. PubMed ID: 990791
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of anti-factor VIII antibodies.
    Blatt PM; White GC; McMillan CW; Roberts HR
    Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of certain commercial prothrombin complex concentrates in treatment of patients with inhibitors of factors VIII and IX.
    Penner JA; Abildgaard CF
    N Engl J Med; 1979 Mar; 300(10):565-6. PubMed ID: 763264
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Factor VIII inhibitors.
    Deykin D
    N Engl J Med; 1974 Jul; 291(4):205. PubMed ID: 4834491
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation and clinical use of factor IX concentrate PPSB according to Soulier.
    Haanen C; McShine RL; Kunst A
    Vox Sang; 1969 Apr; 16(4):398-411. PubMed ID: 5800593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Factor VIII inhibitor following surgery for epidural hemorrhage in hemophilia: successful therapy with a concentrate containing factors II, VII, IX, and X.
    Goodknight SH; Common HH; Lovrein EW
    J Pediatr; 1976 Feb; 88(2):356-7. PubMed ID: 1249702
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
    Barthels M
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S31-8. PubMed ID: 10499907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prothrombin complex concentrates in the treatment of a hemophilic patient with an inhibitor of factor VIII.
    Sonoda T; Solomon A; Krauss S; Cruz P; Jones FS; Levin J
    Blood; 1976 Jun; 47(6):983-9. PubMed ID: 1276480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Prothrombin complex to treat factor VIII inhibition.
    Tishkoff GH
    N Engl J Med; 1975 Apr; 292(14):754-5. PubMed ID: 1113790
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
    Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
    N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
    Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.